MiR-1208 Increases the Sensitivity to Cisplatin by Targeting TBCK in Renal Cancer Cells

Area of Science:

• Molecular Biology
• Oncology
• Genetics

Background:

• MicroRNAs (miRNAs) are key regulators of gene expression implicated in various human malignancies.
• Reduced expression of miRNA-1208 (miR-1208) in cancer cells suggests its potential role as a tumor suppressor.

Purpose of the Study:

• To investigate the function of miR-1208 in cancer, specifically its role as a tumor suppressor.
• To identify the direct targets of miR-1208 and elucidate its mechanism of action in renal cancer cells.

Main Methods:

• Ectopic expression of miR-1208 in cancer cells.
• Assessment of apoptosis using sub-G1 population analysis and caspase cleavage assays.
• Luciferase reporter assays to confirm direct binding of miR-1208 to TBCK 3'-UTR.
• Analysis of TBCK expression regulation at the transcriptional level.
• siRNA-mediated knockdown of TBCK to evaluate its role in chemoresistance.

Main Results:

• Ectopic miR-1208 expression induced apoptosis, evidenced by sub-G1 accumulation and procaspase-3/PARP cleavage, which was caspase-dependent.
• miR-1208 enhanced the sensitivity of Caki-1 cells to cisplatin and TRAIL.
• miR-1208 directly targets TBCK, repressing its expression transcriptionally.
• Inhibition of miR-1208 increased TBCK expression, while TBCK knockdown mimicked miR-1208's effect on chemoresistance.

Conclusions:

• miR-1208 functions as a tumor suppressor in renal cancer by directly targeting and downregulating TBCK.
• miR-1208 induces apoptosis and sensitizes cancer cells to chemotherapy, highlighting its potential as a therapeutic agent for renal cancer.